Found: 13
Select item for more details and to access through your institution.
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33137-8
- By:
- Publication type:
- Article
Cavβ1 regulates T cell expansion and apoptosis independently of voltage-gated Ca<sup>2+</sup> channel function.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29725-3
- By:
- Publication type:
- Article
Prediction of potent shRNAs with a sequential classification algorithm.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 4, p. 350, doi. 10.1038/nbt.3807
- By:
- Publication type:
- Article
A decision process for drug discovery in retinoblastoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 426, doi. 10.1007/s10637-020-01030-0
- By:
- Publication type:
- Article
Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 590, doi. 10.1007/s10637-017-0557-6
- By:
- Publication type:
- Article
Biophysical profiling of tumor cell lines.
- Published in:
- Analytical Cellular Pathology: Cellular Oncology, 2011, v. 34, n. 5, p. 225, doi. 10.1155/2011/496874
- By:
- Publication type:
- Article
Using CRISPR/Cas to study gene function and model disease in vivo.
- Published in:
- FEBS Journal, 2016, v. 283, n. 17, p. 3194, doi. 10.1111/febs.13750
- By:
- Publication type:
- Article
Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens.
- Published in:
- FEBS Journal, 2016, v. 283, n. 17, p. 3170, doi. 10.1111/febs.13770
- By:
- Publication type:
- Article
Microenvironment-derived factors driving metastatic plasticity in melanoma.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14343, doi. 10.1038/ncomms14343
- By:
- Publication type:
- Article
High-Content, Full Genome siRNA Screen for Regulators of Oncogenic HRAS-Driven Macropinocytosis.
- Published in:
- Assay & Drug Development Technologies, 2015, v. 13, n. 7, p. 347, doi. 10.1089/adt.2015.660
- By:
- Publication type:
- Article
Combined small-molecule treatment accelerates maturation of human pluripotent stem cell-derived neurons.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 10, p. 1515, doi. 10.1038/s41587-023-02031-z
- By:
- Publication type:
- Article
Author Correction: Combined small-molecule treatment accelerates maturation of human pluripotent stem cell-derived neurons.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
RABiT-III: an Automated Micronucleus Assay at a Non-Specialized Biodosimetry Facility.
- Published in:
- Radiation Research, 2024, v. 201, n. 6, p. 567, doi. 10.1667/RADE-23-00120.1
- By:
- Publication type:
- Article